Kato K. Vitrification of embryos and oocytes for fertility preservation in cancer patients. Reprod Med Biol, 2016; 15:227–233.Google Scholar

Alvarez M, Solé M, Devesa M, et al. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online, 2014;28(6):663–668.Google Scholar

Rodgers RJ, Reid GD, Koch J, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod, 2017;32(5):1033–1045.CrossRefGoogle Scholar

Dolmans M Demylle D, Martínez-Madrid B, Donnez J. Efficacy of in vitro fertilization after chemotherapy. Fertil Steril, 2005;83:897–901.CrossRefGoogle Scholar

Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol, 2005;23:3858–3859.Google Scholar

Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature, 1983;305(5936):707–709.Google Scholar

Veiga A, Calderón G, Barri PN, Coroleu B. Pregnancy after the replacement of a frozen– thawed embryo with less than 50% intact blastomeres. Hum Reprod, 1987;2(4):321–323.Google Scholar

Wenherholm UB, Södertrom Anttila V et al. Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod, 18(6):815–820.Google Scholar

Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med, 2009;360:902–911.Google Scholar

Loutradis KE, Kolibianakis EM, Venetis CA et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril, 2008;90 (1):186–193.Google Scholar

Rienzi L, Gracia C, Maggiulli R, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update, 2017;23(2):139–155.Google Scholar

Check JH, Summers-Chase D, Yuan W, Swenson K, Horwath D. Length of time of embryo storage does not negatively influence pregnancy rates after thawing and transfer. Clin Exp Obstet Gynecol, 2010;37(3):185–186.Google Scholar

Yuan Y, Mai Q, Ma J, et al. What was the fate of human embryos following long-term cryopreservation (≥12 years) and frozen embryo transfer?. Hum Reprod, 2019;34(1):52–55. CrossRefGoogle Scholar

Li J, Yin M, Wang B, et al. The effect of storage time after vitrification on pregnancy and neonatal outcomes among 24 698 patients following the first embryo transfer cycles. Hum Reprod, 2020;35(7):1675–1684.Google Scholar

Takahashi K, Mukaida T, Goto T, Oka C. Perinatal outcome of blastocyst transfer with vitrification using Cryoloop: a 4 year follow-up study. Fertil Steril, 2005;84:88–92.CrossRefGoogle Scholar

Rama Raju GA, Prakash GY, Krishna KM, Madam K. Neonatal outcome after vitrified day 3 embryo transfers: a preliminary study. Fertil Steril, 2009;92:143–148.Google Scholar

Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: early clinical experience. Fertil Steril, 2010;94:149–155.Google Scholar

Luna M, Boada M, Aran B et al. Couples’ opinions regarding the fate of surplus frozen embryos. Reprod Biomed Online, 2009;19(Suppl. 2):11–15.CrossRefGoogle Scholar

Brown JP, Moden E, Obasaju M, Ying YK. Natural cycle in vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast. Hum Reprod, 1996;11:197–199.Google Scholar

Juretzka MJ, O’Hanlan KA, Katz SL, El-Danasouri I, Westphal LM. Embryo cryopreservation after diagnosis of stage IIB endometrial cancer and subsequent pregnancy in a gestational carrier. Fertil Steril, 2005;83:1041–1045.Google Scholar

Oktay K, Sönmezer M. Fertility preservation in gynecological cancers. Curr Opin Oncol, 2007;19:506–511.Google Scholar

Yang, D, Brown, SE, Nguyen, K et al. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertil Steril, 2007;87(6):1469 e1–4.CrossRefGoogle ScholarPubMed

Ataman, LM, Rodrigues, JK, Marinho, RM et al. Creating a global community of practice for oncofertility. J Glob Oncol, 2016;2:83–96.Google Scholar

Meirow, D, Epstein, M, Lewis, H, Nugent, D, Gosden, RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod, 2001;16:632–637.Google Scholar

Bernatsky, S, Clarke, AE, Suissa, S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med, 2008;168:378–381.Google Scholar

Schroeder, JO, Euler, HH, Loffler, H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med, 1987;107:344–346.CrossRefGoogle ScholarPubMed

Langford, CA. Update on Wegener granulomatosis. Cleve Clin J Med, 2005;72:689–690, 693–697.Google Scholar

Rauck, AM, Grovas, AC. Bone marrow transplantation in adolescents. Adolesc Med, 1999;10:445–449, xi–xii.Google Scholar

Berlanda, N, Vercellini, P, Fedele, L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Curr Opin Obstet Gynecol, 2010;22:320–325.Google Scholar

Garcia-Velasco, JA, Somigliana, E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod, 2009;24:496–501.Google Scholar

Stoop, D, Cobo, A, Silber, S. Fertility preservation for age-related fertility decline. Lancet, 2014;384:1311–1319.Google Scholar

Cobo, A, Garcia-Velasco, JA. Why all women should freeze their eggs. Curr Opin Obstet Gynecol, 2016;28:206–210.Google Scholar

Garcia-Velasco, JA, Domingo, J, Cobo, A et al. Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril, 2013;99:1994–1999.Google Scholar

Imbert, R, Moffa, F, Tsepelidis, S et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod, 2014;29:1931–1940.Google Scholar

Donnez, J, Dolmans, MM. Fertility preservation in women. N Engl J Med, 2017;377:1657–1665.Google Scholar

Kim, SY, Kim, SK, Lee, JR, Woodruff, TK. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. J Gynecol Oncol, 2016;27:e22.Google Scholar

Diaz-Garcia, C, Domingo, J, Garcia-Velasco, J et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril, 2018;109(3):478–485.Google Scholar

Dolmans, MM, Manavella, DD. Recent advances in fertility preservation. J Obstet Gynaecol Res, 2019;45:266–279.Google Scholar

Mahajan, N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci, 2015;8:3–13.Google Scholar

Chen, C. Pregnancy after human oocyte cryopreservation. Lancet, 1986;1:884–886.Google Scholar

Fahy, GM, Wowk, B, Wu, J, Paynter, S. Improved vitrification solutions based on the predictability of vitrification solution toxicity. Cryobiology, 2004;48:22–35.Google Scholar

Rall, WF, Fahy, GM. Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification. Nature, 1985;313:573–575.Google Scholar

Coello, A, Campos, P, Remohi, J, Meseguer, M, Cobo, A. A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study. J Assist Reprod Genet, 2016;33:413–421.CrossRefGoogle ScholarPubMed

Cobo, A, Kuwayama, M, Perez, S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril, 2008;89:1657–1664.Google Scholar

Seki, S, Mazur, P. The dominance of warming rate over cooling rate in the survival of mouse oocytes subjected to a vitrification procedure. Cryobiology, 2009;59:75–82.CrossRefGoogle ScholarPubMed

Cobo, A, Serra, V, Garrido, N et al. Obstetric and perinatal outcome of babies born from vitrified oocytes.Fertil Steril, 2014;102:1006–1015.e4.Google Scholar

Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7:535–543.CrossRefGoogle ScholarPubMed

Poniatowski, BC, Grimm, P, Cohen, G. Chemotherapy-induced menopause: a literature review. Cancer Invest, 2001;19:641–648.Google Scholar

Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 2006;11:422–434.Google Scholar

Qin, N, Chen, Q, Hong, Q et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril, 2016;106:334–341.e1.Google Scholar

Ubaldi, FM, Capalbo, A, Vaiarelli, A et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril, 2016;105:1488–1495.e1.Google Scholar

Cakmak, H, Rosen, MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol, 2015;27:215–221.Google Scholar

Kim, JH, Kim, SK, Lee, HJ et al. Efficacy of random-start controlled ovarian stimulation in cancer patients. J Korean Med Sci, 2015;30:290–295.Google Scholar

Cobo, A, Garcia-Velasco, J, Domingo, J, Pellicer, A, Remohi, J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod, 2018;33:2222–2231.Google Scholar

Platet, N, Cathiard, AM, Gleizes, M, Garcia, M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol, 2004;51:55–67.Google Scholar

Butt, AJ, Caldon, CE, McNeil, CM et al. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol, 2008;630:189–205.Google Scholar

Oktay, K, Turan, V, Bedoschi, G, Pacheco, FS, Moy, F. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol, 2015;33:2424–2429.Google Scholar

Domingo, J, Garcia-Velasco, JA. Oocyte cryopreservation for fertility preservation in women with cancer. Curr Opin Endocrinol Diabetes Obes, 2016;23:465–469.Google Scholar

Sanchez-Serrano, M, Crespo, J, Mirabet, V et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril, 2010;93:268.e11–268.e13.Google Scholar

Kim, MK, Lee, DR, Han, JE et al. Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation. J Assist Reprod Genet, 2011;28:1167–1170.Google Scholar

Alvarez, M, Sole, M, Devesa, M et al. Live birth using vitrified–warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online, 2014;28:663–668.Google Scholar

da Motta, EL, Bonavita, M, Alegretti, JR, Chehin, M, Serafini, P. Live birth after 6 years of oocyte vitrification in a survivor with breast cancer. J Assist Reprod Genet, 2014;31:1397–1400.Google Scholar

Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril, 2016;105:755–64.e8.Google Scholar

Doyle, JO, Richter, KS, Lim, J et al. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril, 2016;105:459–466.e2.Google Scholar

Cardozo, ER, Thomson, AP, Karmon, AE et al. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. J Assist Reprod Genet, 2015;32:587–596.Google Scholar

Quinn, MM, Cakmak, H, Letourneau, JM, Cedars, MI, Rosen, MP. Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod, 2017;32:568–574.Google Scholar

Dolinko, AV, Farland, LV, Missmer, SA et al. Responses to fertility treatment among patients with cancer: a retrospective cohort study.Fertil Res Pract, 2018;4:3–018-0048–2. eCollection 2018.Google Scholar

Tsampras, N, Roberts, SA, Gould, D, Fitzgerald, CT. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients. Eur J Cancer Care (Engl), 2018;27:e12797.Google Scholar

Friedler, S, Koc, O, Gidoni, Y, Raziel, A, Ron-El, R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril, 2012;97:125–133.Google Scholar

Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab, 2006;91:3885–3890.Google Scholar

Domingo, J, Guillen, V, Ayllon, Y et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril, 2012;97:930–934.Google Scholar

Deighton, KJ. Cancer–a systemic disease with local manifestations. Med Hypotheses, 1975;1:37–41.Google Scholar

Jatoi, I. Breast cancer: a systemic or local disease? Am J Clin Oncol, 1997;20:536–539.Google Scholar

Leone, BA, Leone, J, Leone, JP. Breast cancer is a systemic disease rather than an anatomical process. Breast Cancer Res Treat, 2017;161:619–017-4104–0. Epub 2017 January 9.CrossRefGoogle ScholarPubMed

Goldman, RH, Racowsky, C, Farland, LV et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod, 2017;32:853–859.Google Scholar

Kavic, SM, Sauer, MV. Oocyte donation treats infertility in survivors of malignancies: 10-year experience. J Assist Reprod Genet, 2001;18(3):181–183.Google Scholar

Edgar, A, Morris, EMM, Kelnar, CJH, Wallace, WH. Long-term follow-up of survivors of childhood cancer. Endoc Dev, 2009;15:159–180.Google Scholar

Del Mastro, L, Catzeddu, T, Venturini, M. Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev, 2006;32(6):417–422.Google Scholar

Meirow, D, Epstein, M, Lewis, H, Nugent, D, Gosden, RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod, 2001;16(4):632–637.Google Scholar

Hawkins, MM. Pregnancy outcome and offspring after childhood cancer. BMJ, 1994;309(6961):1034.CrossRefGoogle ScholarPubMed

Sanders, JE, Hawley, J, Levy, W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996;87(7):3045–3052.Google Scholar

Larsen, EC, Loft, A, Holm, K et al. Oocyte donation in women cured of cancer with bone marrow transplantation including total body irradiation in adolescence. Hum Reprod, 2000;15(7):1505–1508.CrossRefGoogle ScholarPubMed

Bath, LE, Critchley, HO, Chambers, SE et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol, 1999;106(12):1265–1272.Google Scholar

Urbano, MT, Tait, DM. Can the irradiated uterus sustain a pregnancy? A literature review. Clin Oncol, 2004;16(1):24–28.Google Scholar

Fenig, E, Mishaeli, M, Kalish, Y, Lishner, M. Pregnancy and radiation. Cancer Treat Rev, 2001;27(1):1–7.Google Scholar

Yih, MC, Spandorfer, SD, Rosenwaks, Z. Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories. Fertil Steril, 2005;83(1):24–29.Google Scholar

Bath, LE, Wallace, WH, Shaw, MP, Fitzpatrick, C, Anderson, RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod, 2003;18(11):2368–2374.Google Scholar

Larsen, EC, Müller, J, Rechnitzer, C, Schmiegelow, K, Andersen, AN. Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l. Hum Reprod, 2003;18(2):417–422.Google Scholar

Azim, AA, Rauch, ER, Ravich, Witkin S, Oktay, K. Ovarian reserve is impaired in cancer patients with normal baseline FSH who previously received chemotherapy as determined by response to controlled ovarian stimulation and anti-mullerian hormone measurements: a controlled study. Fertil Steril, 2006;86(3):S123–S124.Google Scholar

Ginsburg, ES, Yanushpolsky, EH, Jackson, KV. In vitro fertilization for cancer patients and survivors. Fertil Steril, 2001;75(4):705–710.Google Scholar

Azim, A, Costantini-Ferrando, M, Oktay, K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol, 2008;26(16):2630–2635.Google Scholar

Azim, AA, Rauch, ER, Ravich, M, Witkin, S, Oktay, K. Ovarian reserve is impaired in cancer patients with normal baseline FSH who previously received chemotherapy as determined by response to controlled ovarian stimulation and anti-Müllerian hormone measurements: a controlled study. Fertil Steril, 2006;86(3):S123–S124.Google Scholar

Oktay, K, Buyuk, E, Libertella, N, Akar, M, Rosenwaks, Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol, 2005;23(19):4347–4353.Google Scholar

Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab, 2006;91(10):3885–3890.Google Scholar

Suikkari, A. In-vitro maturation: its role in fertility treatment. Curr Opin Obstet Gynecol, 2008;20(3):242–248.Google Scholar

Banwell, KM, Thompson, JG. In vitro maturation of mammalian oocytes: outcomes and consequences. Semin Reprod Med, 2008;26(2):162–174.Google Scholar

Bustillo, M, Buster, JE, Cohen, SW et al. Delivery of a healthy infant following nonsurgical ovum transfer. JAMA, 1984;251(7):889.Google Scholar

Lutjen, P, Trounson, A, Leeton, J et al. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature, 1984;307(5947):174–175.Google Scholar

Rosenwaks, Z, Veeck, LL, Liu, HC. Pregnancy following transfer of in vitro fertilized donated oocytes. Fertil Steril, 1986;45(3):417.Google Scholar

National Summary Report for 2015. Society for Assisted Reproductive Technology (SART). www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0“ www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0Google Scholar

Anselmo, AP, Cavalieri, E, Aragona, C et al. Successful pregnancies following an egg donation program in women with previously treated Hodgkin’s disease. Haematologica, 2001;86(6):624–628.Google Scholar

Clarke, A, Gaff, C. Challenges in the genetic testing of children for familial cancers. Arch Dis Child, 2008;93(11):911–914.Google Scholar

Offit, K, Kohut, K, Clagett, B et al. Cancer genetic testing and assisted reproduction. J Clin Oncol, 2006;24(29):4775–4782.Google Scholar

Sagi, M, Weinberg, N, Eilat, A et al. Preimplantation genetic diagnosis for BRCA1/2 – a novel clinical experience. Prenat Diagn, 2009;29(5):508–513.Google Scholar

Xu, K, Rosenwaks, Z, Beaverson, K et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am J Ophthalmol, 2004;137(1):18–23.Google Scholar

Julian-Reynier, C, Chabal, F, Frebourg, T et al. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer. J Clin Oncol, 2009;27(27):4475–4480.Google Scholar

Lammens, C, Bleiker, E, Aaronson, N et al. Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Fam Cancer, 2009;8(4):457–464.Google Scholar

Nagy, Z, Chang, C, Shapiro, D et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil Steril, 2009;92(2):520–526.Google Scholar

Alkorta-Idiakez, I. Human tissue and cells regulation in Spain: looking at Europe to solve inner contradictions? Law Human Genome Rev, 2008;29:25–43.Google Scholar

Jones, HW, Cohen, J. IFFS surveillance 07. Fertil Steril, 2007;87(4 Suppl 1):S1–67.Google Scholar

Practices Committee of American Society for Reproductive Medicine and Practices Committee of Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a Committee opinion. Fertil Steril, 2013;99:47–62.Google Scholar

Inhorn, M, Patrizio, P. Rethinking reproductive “tourism” as reproductive “exile.” Fertil Steril, 2009;92:904–906.Google Scholar

Pennings, G, de Wert, G, Shenfield, F et al. ESHRE task force on ethics and law 15: cross-border reproductive care. Hum Reprod, 2008;23(10):2182–2184.Google Scholar

Tremlett, G. Spain becomes the destination of choice for fertility tourists from Britain. Guardian, May 12, 2006:p. 16.Google Scholar

Murphy, C. Rush to Spain for IVF is up 100 pc. Herald, September 9, 2009: www.herald.ie/national-news/rush-to-spain-for-ivf-is-up-100pc-1881428.htmlGoogle Scholar

Andersen, AN, Goossens, V, Bhattacharya, S et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005. Results generated from European registers by the European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod, 2009;24(6):1267.Google Scholar

Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2005 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta, GA: Centers for Disease Control and Prevention, 2007.Google Scholar

The Ethics Committee of the American Society for Reproductive Medicine. Financial compensation of oocyte donors: an Ethics Committee opinion. Fertil Steril, 2016;106(7):e15–e19.Google Scholar

The Ethics Committee of the American Society for Reproductive Medicine. Family members as gamete donors and surrogates. Fertil Steril, 2003;80(5):1124–1130.Google Scholar

US Department of Health and Human Services, US Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), 2007. www.fda.govhttp://www.BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm073964.htm. (Accessed 2009)Google Scholar

Daar, J, Brzyski, R. Genetic screening of sperm and oocyte donors: ethical and policy implications. JAMA, 2009;302(15):1702–1704.Google Scholar

Wallerstein, R, Jansen, V, Grifo, JA et al. Genetic screening of prospective oocyte donors. Fertil Steril, 1998;70(1):52–55.Google Scholar

Maron, B, Lesser, J, Schiller, N et al. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA, 2009;302(15):1681–1684.Google Scholar

Practices Committee of American Society for Reproductive Medicine and Practices Committee of Society for Assisted Reproductive Technology. Guidelines for gamete and embryo donation: a Practice Committee report. Fertil Steril, 2008;90(Suppl.5):S30–S44.Google Scholar

Singer, LM, Brodzinsky, DM, Ramsay, D, Steir, M, Waters, E. Mother–infant attachment in adoptive families. Child Dev, 1985;56(6):1543–1551.Google Scholar

Scarr, S, Weinberg, RA. The Minnesota adoption studies: genetic differences and malleability. Child Dev, 1983;54(2):260–267.Google Scholar

Kalfoglou, AL. Navigating conflict of interest in oocyte donation. Amer J Bioeth, 2001;1(4):W1.Google Scholar

de Melo-Martin, I, Cholst, IN. Researching human oocyte cryopreservation: ethical issues. Fertil Steril, 2008;89(3):523–528.Google Scholar

Maxwell, K, Cholst, I, Rosenwaks, Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril, 2008;90(6):2165–2171.Google Scholar

Sauer, MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Obstet Gynecol, 2001;184(3):277–278.Google Scholar

Bennett, SJ, Waterstone, JJ, Cheng, WC, Parsons, J.Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures. J Assist Reprod Genet, 1993;10(1):72–77.Google Scholar

Bodri, D, Guilln, JJ, Polo, A et al. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online, 2008;17(2):237–243.Google Scholar

Pereira, N, Voskuilen-Gonzalez, A, Hancock, K et al. Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes. Reprod Biomed Online, 2017;35(4):400–406.Google Scholar

Acevedo, B, Gomez-Palomares, JL, Ricciarelli, E, Hernández, ER. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril, 2006;86(6):1682–1687.Google Scholar

Damewood, MD, Shen, W, Zacur, HA et al. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril, 1989;52(3):398–400.Google Scholar

Yen, SS, Llerena, O, Little, B, Pearson, OH. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab, 1968;28(12):1763–1767.Google Scholar

Itskovitz-Eldor, J, Kol, S, Mannaerts, B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome. Preliminary report: short communication. Hum Reprod, 2000;15(9):1965–1968.Google Scholar

Engmann, L, DiLuigi, A, Schmidt, D et al. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril, 2008;89(1):84–91.Google Scholar

Melo, M, Busso, CE, Bellver, J et al. GnRH agonist versus recombinant hCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online, 2009;19(4):486–492.Google Scholar

Sismanoglu, A, Tekin, HI, Erden, HF et al. Ovulation triggering with GnRH agonist vs hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial. J Assist Reprod Genet, 2009;26(5):251–256.Google Scholar

Ludwig, AK, Glawatz, M, Griesinger, G, Diedrich, K, Ludwig, M.Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod, 2006;21(12):3235–3240.Google Scholar

Tureck, RW, Garcıa, CR, Blasco, L, Mastroianni, L. Perioperative complications arising after transvaginal oocyte retrieval. Obstet Gynecol, 1993;81(4):590.Google Scholar

Jun, S, Hornstein, M. Is there a role for preparatory cycle in ovum donation recipients? Curr Opin Obstet Gynecol, 2006;18(3):333–337.Google Scholar

Rosenwaks, Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril, 1987;47(6):895–909.Google Scholar

Droesch, K, Navot, D, Scott, R et al. Transdermal estrogen replacement in ovarian failure for ovum donation. Fertil Steril, 1988;50(6):931–934.Google Scholar

Davis, OK, Rosenwaks, Z. Preparation of the endometrium for oocyte donation. J Assist Reprod Genet, 1993;10(7):457–459.Google Scholar

Navot, D, Anderson, TL, Droesch, K et al.Hormonal manipulation of endometrial maturation. J Clin Endocrinol Metab, 1989;68(4):801–807.Google Scholar

Navot, D, Scott, RT, Droesch, K et al. The window of embryo transfer and the efficiency of human conception in vitro. Fertil Steril, 1991;55(1):114–118.Google Scholar

Gibbons, WE, Toner, JP, Hamacher, P, Kolm, P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril, 1998;69(1):96–101.Google Scholar

Scott, R, Navot, D, Liu, HC, Rosenwaks, Z. A human in vivo model for the luteoplacental shift. Fertil Steril, 1991;56(3):481–484.Google Scholar